Nurix's Series B Round

Nurix raised a round of funding on May 22, 2014.

Nurix is an early-stage biotechnology company with an allosteric drug discovery platform which offers inroads to previously intractable targets. The company's current focus is on the discovery and dev…

Articles about Nurix's Series B Round: